$阿里巴巴(BABA)$Loop Capital stated what most of us already thought. Why would BABA be concerned about PDD blow-up? In fact, $阿里巴巴(BABA)$ must be feeling really nice cause its main competitor over the last two years is finally struggling and most likely cause of BABA regaining market share.Once again, use common sense
$Unity Software Inc.(U)$ Does anybody else sit and think damn this was over $200 just recently? And the metaverse, gaming, movies & tv need this tech to bring imagination to reality. The macro affected the price but the company's story remains the same. Well now for sure, FB is out of the race to buy U. MSFT is out after buying Activision. Only left Apple, Google and Amazon as a potential buyer. If Google
$BigBear.ai Holdings(BBAI)$ As of Aug 4, institutional holdings reached 29.8%, up 5.3 percentage points from Jul 21. Trading volume has stabilized recently with noticeably improved concentration, maintaining a positive outlook.
$Robinhood(HOOD)$ didn't disappoint this time! The zero-commission broker is regaining attention as rate hikes wind down, with its newly launched retirement accounts gaining traction. Their innovation potential remains promising - holding for next quarter's user growth metrics!
$Meta Platforms, Inc.(META)$can not believe its -ve now. what a manipulation..biggest scam is stock market.Its sad that whole market has become a casino with authorities have no control on the scams that is happening
$Apple(AAPL)$ Apple stock climbed 2.1% to 166.56, but stopped short at its 21-day line. Investors could view AAPL stock as having a double-bottom base with a 176.75 buy point. Investors could use a trendline from the early January all-time high to find slightly early entry modestly above the 50-day line. The RS line for Apple stock is just below record levels
$Rigetti Computing(RGTI)$ is on a nice uptrend! The key level to watch is a solid break above $46. If that happens, the next price target could be in the $49-$55 range. Plenty of room to run, staying bullish!
$BABA-W(09988)$ didn’t just invest in Meitu for its potential, it’s also likely a smart hedge against its collaboration with $Apple(AAPL)$ . At the heart of it lies one key factor: artificial intelligence. Meitu’s strength in vertical AI applications, especially in imaging and design, clearly stood out. That’s what convinced Alibaba to back it with serious capital, helping push forward costly R&D in large models. Meanwhile, tools like Meitu Design Studio align perfectly with Alibaba’s push to improve merchant services on its e-commerce platforms. This partnership looks like a well-calculated win-win move with strategic alignment on both sides.
$英伟达(NVDA)$ Goldman Sachs said in a statement that they see a lot of stock pickers starting to buy up growth stocks, Taiwanese government stating that the war in Russia has barely any effect on the chip industry, Iron clad balance sheet, Tons of stable projected growth in the future with every single department within nvidia growing at huge rates, definitely in terms of big data. By march Nvidia will hold the&nb
$拼多多(PDD)$Certainly! Without a dividend, I believe the stock will likely return to $60. Many Chinese investors place a high value on dividends, and if they are not offered, we can expect a significant number of them to exit..🤷🏻♂️
CARsgen-B(02171) up 8% today, strong move! Biotech’s entering a shakeout phase, and when the sector diverges, true leaders shine. CARsgen looks like it’s leading the charge, could have more room to run!
$MINISO Group Holding Limited(MNSO)$ ’s been buying back shares like crazy lately, and that definitely got my attention. I listened to a few speeches by Ye Guofu gotta say, he makes sense. This whole “quality-first” strategy sounds solid to me. At this price, it’s honestly hard to resist. So yeah… I added more. Not financial advice, but personally, I’m feeling pretty bullish. Feels like one of those hidden gems that’s just waiting to shine!
$HUTCHMED(00013)$ The biotech sector is experiencing a valuation re-rating, with industry leaders like HUTCHMED and $INNOVENT BIO(01801)$ leading the way. This year marks a turning point, not just for the broader Hong Kong stock market but also for innovative drugmakers. While much attention has been on Hang Seng Tech and Internet sectors, the Hong Kong Biotech ETF (SZ159570) has surged 32% year-to-date, significantly outperforming tech and internet ETFs. Positive catalysts such as improving drug procurement policies, booming License out deals from major players like Hengrui, and Innovent’s stellar earnings report have fueled this rally. With Hong Kong-listed biotech stocks showing stronger rebounds due
$Zai Lab Ltd(ZLAB)$ Chinese healthcare stocks are looking promising this year, performing really well. Hong Kong stocks are also doing great. Keep it up!
$Palantir Technologies Inc.(PLTR)$ Palantir, a controversial tech stock, has silenced the skeptics with its stellar performance! Despite a sky-high P/E ratio of 304.47, it delivered an astonishing 293% return over the past year. The AI boom has unlocked limitless potential for this company, and the $50 SAR trigger is a testament to its bright future. Thanks to Wedbush and UBS analysts for shedding light on its AI dominance. This AI star stock remains on my watchlist!
$Intel(INTC)$this stock will not recover until Pat is gone. Wall Street has lost confidence in his ability to turn around and does not trust his ever changing promises.
$XPeng Inc.(XPEV)$In the last 6 years over 400 EVs companies in China file bankruptcy,Xpev is a very small player with very low sales. They overpromise and underdeliver for 10 years already. They have a very small market share in China and they are promising factories in Europe. Some people needs to believe them because they are losing sometimes a lot of money and they hope new buyers will help them recoup their money. It’s not a good time to be invested in any company from China unless you hate money.